Foxp3-expressing CD4 + regulatory T (Treg) cells need to differentiate into effector Treg (eTreg) cells to maintain immune homeostasis. T-cell receptor (TCR)-dependent induction of the transcription factor IRF4 is essential for eTreg differentiation, but how IRF4 activity is regulated in Treg cells is still unclear. Here we show that the AP-1 transcription factor, JunB, is expressed in eTreg cells and promotes an IRF4-dependent transcription program. Mice lacking JunB in Treg cells develop multi-organ autoimmunity, concomitant with aberrant activation of T helper cells. JunB promotes expression of Treg effector molecules, such as ICOS and CTLA4, in BATF-dependent and BATF-independent manners, and is also required for homeostasis and suppressive functions of eTreg. Mechanistically, JunB facilitates the accumulation of IRF4 at a subset of IRF4 target sites, including those located near Icos and Ctla4. Thus, JunB is a critical regulator of IRF4-dependent Treg effector programs, highlighting important functions for AP-1 in Treg-mediated immune homeostasis.
R egulatory T (Treg) cells can suppress a variety of immune responses and contribute to immune homeostasis 1, 2 . They require the lineage-specifying transcription factor, forkhead box P3 (Foxp3), for development, maintenance of cell identity, and suppressive functions [3] [4] [5] . Thymic Treg (tTreg) cells develop in the thymus and then circulate through blood and lymphoid tissues as central Treg (cTreg) cells, displaying a CD62L high (hi) phenotype 6 . While circulating in the periphery, some cTreg cells differentiate into effector Treg (eTreg) cells, exhibiting an activated cell phenotype (CD62L low (lo) ), depending on T-cell receptor (TCR) stimuli 7 . cTreg and eTreg cells express various genes differentially and perform non-redundant functions 6, [8] [9] [10] [11] [12] [13] . For example, cTreg cells express lymph node-homing receptors CD62L and CC chemokine receptor 7 (CCR7), whereas eTreg cells preferentially express other chemokine receptors and accumulate in non-lymphoid tissues 14, 15 . In addition, eTreg cells express higher levels of Treg effector molecules, such as inducible T-cell costimulator (ICOS) and cytotoxic T-cell-associated antigen 4 (CTLA4), than do cTreg cells, which are likely important for eTreg-suppressive functions and homeostasis 7, 14, [16] [17] [18] . Furthermore, eTreg cells can express transcription factors, T-box transcription factor (T-bet), GATA-binding protein 3 (GATA3), and retinoic acid receptor-related orphan receptor (ROR)γt, which are associated with roles unique to eTreg cells, to regulate functions of distinct T helper cells [19] [20] [21] [22] [23] [24] .
To activate the effector program, Treg cells require TCRdependent transcriptional regulatory mechanisms that CD4 + Foxp3 − conventional T (Tconv) cells also use for differentiation 12, [25] [26] [27] . For example, the transcription factor, interferon regulatory factor 4 (IRF4), which promotes differentiation of several types of T helper cells and cytotoxic CD8 + T cells [28] [29] [30] [31] [32] , is induced in Treg cells upon TCR stimulation and participates in eTreg differentiation 7, 33 . Treg-specific Irf4-deficient mice develop multi-organ autoimmunity, exhibiting profound Th2 responses 34 . Furthermore, basic leucine zipper transcription factor ATF-like (BATF), one of the AP-1 family of transcription factors, which is also essential for differentiation of Th17 cells and cytotoxic CD8 + T cells 35, 36 , is highly expressed in eTreg cells, and Batf-deficient Treg cells cannot suppress T-cellmediated colitis 24 . BATF and IRF4 bind to AP-1-IRF-composite element (AICE) motifs [37] [38] [39] [40] , but how BATF and other AP-1 transcription factors regulate IRF4 activity in the eTreg transcriptional program is not fully understood.
JunB is another member of the AP-1 family of transcription factors 37 . AP-1 factors contain basic leucine zipper (bZIP) domains, by which they form homodimers or heterodimers with other AP-1 or bZIP-containing transcription factors 41 . JunB can dimerize with BATF in a variety of cells, including CD8 + T cells and Th17 cells 37 . We and other groups recently reported that JunB regulates the BATF-and IRF4-dependent Th17 cell transcriptional program that is critical for pathogenic functions of Th17 cells [42] [43] [44] [45] . JunB promotes DNA-binding of BATF and IRF4 at IRF4 target sites, including those associated with Th17-related genes, Rorc and Il23 receptor (Il23r), during Th17 differentiation 42, 43 . However, functions of JunB in Treg cells remain unclear.
Here, we show that JunB is expressed in eTreg cells, and is required for eTreg-mediated immune homeostasis. Treg-specific deletion of JunB induces severe inflammation in lung and colon. JunB facilitates expression of ICOS and CTLA4 in BATFdependent and -independent fashions, and is pivotal for homeostasis and suppressive functions of eTreg cells. Mechanistically, JunB is required for DNA-binding of IRF4 at IRF4 target sites associated with Icos and Ctla4. Thus, we show crucial functions for JunB in the IRF4-dependent eTreg transcriptional program.
Results

JunB expression in Treg cells. To understand JunB functions in
Treg cells, we first analyzed expression of JunB in murine Treg cells by flow cytometry. In spleen, a subset of Foxp3 + Treg cells, but not Foxp3 − Tconv cells, expressed substantial levels of JunB ( Fig. 1a and Supplementary Fig. 1a ). Moreover, in lung, Treg cells, as well as Tconv cells, uniformly expressed high levels of JunB, and the expression level of JunB in Treg cells was significantly higher than in Tconv cells (Fig. 1b) . We next assessed whether there is a correlation between JunB expression and distinct Treg subpopulations. cTreg cells circulate through secondary lymphoid organs, whereas eTreg cells preferentially accumulate in peripheral tissues 6, 14, 24 . We analyzed JunB expression in CD62L hi C-D44 lo cTreg cells and CD62L lo eTreg cells ( Supplementary  Fig. 1b) . Consistent with enrichment of JunB-expressing Treg cells in the lung, we found that JunB was expressed in eTreg cells, but not in cTreg cells in spleen (Fig. 1c) . eTreg cells heterogeneously express surface molecules such as ICOS, T-cell immunoreceptor with Ig and ITIM domains (TIGIT), and killer cell lectin-like receptor 1 (KLRG1) 11, 18, 24, [46] [47] [48] [49] . We noted that JunB expression was correlated with expression of ICOS, TIGIT, and KLRG1 ( Fig. 1d and Supplementary Fig. 1c, d ). As reported previously, IRF4 and BATF 24, 33, 34 , which are required for eTreg differentiation, were also expressed at elevated levels in ICOSexpressing eTreg cells ( Supplementary Fig. 1e , f). JunB expression can be regulated transcriptionally and post-transcriptionally in various signaling pathways 50, 51 . To determine whether induction of JunB is transcriptionally regulated in eTreg cells, we sorted cTreg and eTreg cells by fluorescence-activated cell sorting (FACS) and analyzed expression of mRNA for Junb, as well as Batf and Irf4, by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) analysis. Although mRNA expression of Batf and Irf4 was upregulated in eTreg cells, there was no difference of Junb mRNA expression between cTreg and eTreg cells (Fig. 1e ), suggesting that, unlike BATF and IRF4, JunB expression is regulated post-transcriptionally in eTreg cells. These data indicate that JunB is expressed in a subset of eTreg cells.
To investigate how JunB expression is regulated in Treg cells, we examined expression of JunB, as well as of BATF and IRF4, in TCR-stimulated Treg cells, because TCR signaling is necessary for differentiation of eTreg cells 7, 52 . We isolated CD4 + CD25 + Treg cells from spleens and confirmed that > 95% of the cells expressed Foxp3 (Supplementary Fig. 1g ). We activated Treg cells with anti-CD3 and anti-CD28 antibodies in the presence of interleukin (IL) −2. Flow cytometry analysis showed that expression of JunB and BATF was induced by both anti-CD28 antibody and IL-2 stimulation in an additive manner, compared with expression levels in Treg cells stimulated with anti-CD3 antibody alone (Fig. 1f) . On the other hand, IRF4 expression was markedly induced by stimulation with anti-CD3 antibody alone, and it was further enhanced by either anti-CD28 antibody or IL-2 stimulation (Fig. 1f) . However, the additive effect of anti-CD28 antibody and IL-2 stimulation was not observed in IRF4 expression (Fig. 1f) . In summary, these results suggest that dynamic expression of JunB in TCR-stimulated Treg cells might regulate generation and/or function of eTreg cells.
Treg-specific deletion of JunB induces autoimmunity. To investigate physiological functions of JunB in Treg cells, we crossed mice harboring loxp-flanked Junb alleles (Junb fl/fl ) with mice harboring Foxp3 promoter-driven cre recombinase (Foxp3 Cre ). This generated Treg-specific, Junb-deficient (Foxp3-Cre Junb fl/fl ) mice ( Supplementary Fig. 2a ). Flow cytometry analysis confirmed efficient deletion of JunB in CD4 + Foxp3 − Treg cells in Foxp3 Cre Junb fl/fl mice ( Supplementary Fig. 2a ). In contrast, substantial numbers of CD4 + Foxp3 − Tconv cells and CD8 + T cells expressed JunB in the lung and colon of Foxp3 Cre Junb fl/fl mice ( Supplementary Fig. 2a ), albeit at a lower number compared with control mice, probably owing to leaky expression of Cre in these cells 53 . Foxp3 Cre Junb fl/fl mice were born at normal mendelian ratios, but they were markedly smaller, and by 4 weeks of age their weights were already significantly lower than those of control mice ( Fig. 2a and Supplementary  Fig. 2b ). About 60% of Foxp3 Cre Junb fl/fl mice died within 6 months (Fig. 2b) . We observed significant increases in size and cellularity of cervical lymph nodes, but not other lymph nodes and spleens in Foxp3 Cre Junb fl/fl mice, compared with Foxp3 CreJunb +/+ mice ( Fig. 2c and Supplementary Fig. 2c ). In histopathological analysis, Foxp3 Cre Junb fl/fl mice exhibited higher inflammation scores in lung and colon (but not in liver or skin), than did control mice (Fig. 2d) .
In Foxp3 Cre Junb fl/fl mice, although increased cellularity was restricted to cervical lymph nodes (Fig. 2c) , frequencies of CD4 + Foxp3 − Tconv cells exhibiting the activated cell phenotype (CD62L lo CD44 hi ) were markedly more abundant than in Foxp3-Cre Junb +/+ mice in all secondary lymphoid tissues analyzed and in lung (Fig. 2e, Supplementary Fig. 2d ). Total B cells (B220 + CD19 + ), germinal center B cells (B220 + CD19 + GL-7 + Fas + ), and plasma cells (CD138 + B220 − ) were also significantly increased in the cervical lymph nodes, but not in the spleen or Peyer's patches, in
Foxp3
Cre Junb fl/fl mice, compared with Foxp3 Cre Junb +/+ mice ( Supplementary Fig. 3a-c) . Furthermore, mass cytometry analysis revealed increased frequencies of granulocytes with unaltered JunB expression levels in these cells in spleens of Foxp3 Cre Junb fl/fl mice (Fig. 2f) , indicating that JunB in Treg cells is important for maintenance of leukocyte homeostasis. We also analyzed levels of serum immunoglobulins by enzyme-linked immunosorbent assay (Fig. 3a) , suggesting that a decrease of Treg cells might partly explain the more severe inflammation observed in the colon of Foxp3 Cre Junb fl/fl mice. In contrast, abundance of CD4 + Foxp3 + Treg cells was normal in lung, liver, and skin, and only slightly reduced in spleen in Foxp3 Cre Junb fl/fl mice ( Fig. 3a and Supplementary Fig. 4a ), suggesting that inflammation induced in lung and spleen of the mice might not be due to loss of Treg cells.
To further explore why Treg-mediated self-tolerance cannot be maintained in Foxp3 Cre Junb fl/fl mice, we next analyzed abundance of eTreg cells, as JunB was expressed in this population. Foxp3 Cre Junb fl/fl mice had normal or even increased numbers of CD62L lo eTreg cells in the spleen and lung, but not in the colon, compared with Foxp3 Cre Junb +/+ mice ( Fig. 3b and supplementary Fig 4b, c) . However, the mean fluorescence intensity (MFI) of CD44 was reduced in Junb-deficient eTreg cells (Fig. 3b, c) . We also analyzed expression of Treg signature molecules and found that there was no reduction in expression of CTLA4 and CD25 in eTreg and cTreg cells of Foxp3 Cre Junb fl/fl mice (Fig. 3d) . GITR (Glucocorticoid-Induced TNF receptor family-related protein) was even upregulated in both eTreg and cTreg cells of Foxp3 Cre Junb fl/fl mice, probably owing to effects of inflammation (Fig. 3d) . Moreover, we analyzed expression of eTreg-related molecules and found that in Junb-deficient eTreg cells, ICOS expression was severely diminished, but expression of TIGIT, KLRG1, and ST2 (IL-33 receptor) was not affected ( Fig. 4d ).
To directly examine the functional importance of JunB in Treg cell immune-suppressive activity, we performed an in vitro suppression assay. Junb-deficient Treg cells isolated from Cd4 Cre Junb fl/fl mice or Junb-sufficient Treg cells isolated from Junb fl/fl mice were mixed with activated Tconv cells. Cell trace violet (CTV) staining analysis showed that suppressive activity of Junb-deficient Treg cells was significantly impaired (Fig. 3f) . Moreover, pre-activation of Treg cells with anti-CD3 antibody enhanced suppression activity of Junb-sufficient Treg cells, but not Junb-deficient Treg cells (Fig. 3f) . Notably, upon stimulation with anti-CD3 antibody, there was a significant increase of annexin-V + cells in Junb-deficient Treg cells, compared with Junb-sufficient Treg cells ( Supplementary Fig. 5a ). These data suggest that JunB is required for survival of Treg cells upon prolonged and/or strong TCR stimulation, which enhances suppressive activity of Treg cells.
We also performed an in vivo suppression assay by cotransferring Junb-deficient Treg cells (CD4 + CD25 + ) isolated from Cd4 Cre Junb fl/fl or Foxp3 Cre Junb fl/fl mice with wild-type naive CD4 + T cells into Rag1-deficient mice. Unlike Junbsufficient Treg cells, Junb-deficient Treg cells could not suppress weight loss and intestinal pathology in these mice ( Fig. 3g and  supplementary Fig. 5b ). Forty days after transfer, there was no difference in the frequency of Junb-deficient and -sufficient Treg cells in the spleen and lung (Supplementary Fig. 5c ). However, in the mesenteric lymph nodes and colon, frequency of Junbdeficient Treg cells was significantly lower than that of Junbsufficient Treg cells (Supplementary Fig. 5c ). In summary, these data suggest that JunB supports tissue-specific accumulation and suppressive functions of Treg cells. JunB regulates expression of Treg effector genes. In Foxp3 Cre Junb fl/fl mice, Junb-deficient Treg cell phenotypes may be modulated by inflammation. To elucidate JunB function in Treg cells under homeostatic (non-inflammatory) conditions, we used Cd4 Cre Junb fl/fl mice, which show no inflammatory signs, probably owing to impaired activation of T helper cells [42] [43] [44] . We first analyzed Treg cell abundance in various lymphoid and nonlymphoid tissues. Consistent with recent reports 43 , CD4 + Foxp3 + Treg cells were diminished in all tissues examined in Cd4 Cre Junb fl/fl mice, with the greatest reduction in colon (Fig. 4a) . This implies that JunB is required for the accumulation of Treg cells under non-inflammatory conditions.
We then analyzed eTreg cell abundance in Cd4 Cre Junb fl/fl mice. In spleens of Cd4 Cre Junb fl/fl mice, the proportion of CD62L lo eTreg cells among all Foxp3 + Treg cells was lower than in Junb fl/fl mice (Fig. 4b) . As in diseased Foxp3 Cre Junb fl/fl mice, MFIs of CD44 expression in CD62L lo eTreg cells of Cd4 Cre Junb fl/fl mice were significantly lower than in Junb fl/fl mice (Fig. 4c) . This suggests that JunB is involved in accumulation of eTreg cells under homeostatic conditions. We next assessed expression of signature molecules for Treg cells and eTreg cells in Cd4 Cre Junb fl/fl mice. Expression levels of CTLA4, but not of CD25 and GITR, in eTreg cells were significantly lower in Cd4 Cre Junb fl/fl mice than Junb fl/fl mice (Fig. 4d ). In addition, there was a significant reduction of CD62L lo eTreg cells expressing ICOS, TIGIT, and KLRG1, but not ST2, in spleens of Cd4 Cre Junb fl/fl mice (Fig. 4e) . Although we detected decreases of GATA3 and T-bet in eTreg cells of Foxp3 Cre Junb fl/fl mice, those molecules were normally expressed in eTreg cells of Cd4 Cre Junb fl/fl mice ( Supplementary Fig. 6a ), suggesting that JunB is involved in expression of GATA3 and Tbet only under inflammatory conditions. Assay with antibodies against neurophilin 1 (Nrp1) or Helios, which are markers for Treg cells generated in the thymus (tTreg), revealed that ICOS expression was significantly decreased in Treg populations, regardless of their expression of Nrp1 or Helios (Fig. 4f and Supplementary Fig. 6b ), suggesting that JunB promotes ICOS expression in both tTreg cells and Treg cells induced in periphery (pTreg). We also analyzed expression of eTreg signature molecules in neonates, because Treg cells generated at that age perform unique and essential functions to maintain selftolerance 54 . There was no difference in frequency of Treg cells in the thymus between 1-week-old Cd4 Cre Junb fl/fl and Junb fl/fl neonates ( Supplementary Fig. 6c ). However, expression of ICOS, TIGIT, and KLRG1 in splenic Treg cells was severely decreased in 1-week-old Cd4 Cre Junb fl/fl mice (Fig. 4g) . Taken together, JunB is needed for expression of a subset of effector molecules in eTreg cells and for accumulation of eTreg cells under homeostatic conditions. JunB regulates eTreg homeostasis. We next examined whether cell-intrinsic functions of JunB are required for generation and homeostasis of Treg cells. To this end, we transferred bone marrow (BM) cells from Cd4 Cre Junb fl/fl and Junb fl/fl mice (CD45.2 + ), in combination with equal numbers of wild-type (WT) BM cells (CD45.1 + ), into Rag1 −/− mice, which generated WT:Cd4 Cre Junb fl/fl and WT:Junb fl/fl BM chimeric mice, respectively (Fig. 5a ). These BM chimeric mice had comparable numbers of total Foxp3 + Treg cells in all tissues examined ( Supplementary Fig. 7 ). We then analyzed ratios of cells derived from Cd4 Cre Junb fl/fl and Junb fl/fl BM cells (CD45.2 + ) relative to those derived from WT BM cells (CD45.2 − ) among Treg populations. In the thymus, frequencies of Foxp3 + Treg cells derived from Cd4 Cre Junb fl/fl BM cells were equivalent to those derived from Junb fl/fl BM cells (Fig. 5b) , indicating that cell-intrinsic functions of JunB are not required for development of tTreg cells. In contrast, in spleen and lung, Foxp3 + Treg cells derived from Cd4 Cre Junb fl/fl BM cells were significantly under-represented, compared with those derived from Junb fl/fl BM cells (Fig. 5b) . Furthermore, the reduction of cells derived from Cd4 Cre Junb fl/fl BM was specific to the CD62L lo eTreg population, but not the CD62L hi CD44 lo cTreg population (Fig. 5c ). We also confirmed impaired expression of ICOS and TIGIT in the remaining Junbdeficient CD62L lo eTreg cells (Fig. 5d, e) , indicating that JunB regulates expression of ICOS and TIGIT in a cell-intrinsic manner.
The severe decrease of Junb-deficient eTreg cells in WT: Cd4 Cre Junb fl/fl mice suggests that JunB is important for eTreg homeostasis in a competitive setting. To further investigate this phenotype, we analyzed the effect of JunB deficiency on proliferation of Treg cells, using Ki67 staining. Proportions of Ki67-expressing eTreg cells derived from Junb fl/fl Cd4 Cre BM cells were severely decreased compared with those derived from Junb fl/ fl BM cells (Fig. 5f ). We also analyzed the effect of JunB deficiency on Treg cell death, using Annexin-V staining. Frequencies of Annexin-V-stained eTreg cells derived from Junb fl/fl Cd4 Cre BM cells, but not Junb fl/fl BM cells, were significantly increased (Fig. 5g) . These data suggest that JunB intrinsically promotes proliferation and survival of eTreg cells, which is important for eTreg homeostasis in a competitive environment.
JunB is required for a transcriptional program for eTregs. To understand JunB-dependent transcriptional regulation in Treg cells, we performed RNA-sequence analysis of Junb-sufficient and Junb-deficient Treg cells, isolated from Junb fl/fl and Cd4 Cre Junb fl/fl mice, respectively. In total, 173 genes were downregulated and 137 genes were upregulated in Junb-deficient Treg cells compared with Junb-sufficient Treg cells (p values < 0.05, log2 fold-changes > 0.5 or < 0.5) (Fig. 6a) . Gene ontology analysis of genes differentially expressed in Junb-deficient and -sufficient Treg cells showed enrichment for genes associated with metabolic processes (Supplementary Fig. 8a ). Furthermore, ingenuity pathway analysis (IPA) revealed that differentially expressed genes were associated most significantly with cell survival ( Supplementary  Fig. 8b ). IPA also identified CD3 and CD28 signaling pathways as upstream regulators for genes affected by JunB deficiency (Supplementary Fig. 8c) .
To assess the function of JunB in a transcriptional program for eTreg cells, we compared our data with previously identified eTreg-related genes (genes that ICOS + eTreg cells expressed more highly than did ICOS − eTreg cells) 18 . Among 762 eTregrelated genes, only 70, including Icos, Tigit, Fgl2, Ctla4, and Maf, (Fig. 6a, b) . We also compared our data with previously identified genes regulated by BATF in Treg cells 24 . Compared with JunB, many more eTreg-related genes (256 genes out of 762) were downregulated by BATF deficiency (Fig. 6b) . Expression of only 34 eTreg-related genes, including Icos and Fgl2, was promoted by both JunB and BATF (Fig. 6b) . In addition, expression of 36 eTreg-related genes, including Ctla4, Tigit, and Maf was upregulated by JunB, but not BATF, whereas expression of 222 eTreg-related genes, including Prdm1 and Nt5e was promoted by BATF, but not JunB (Fig. 6b) . In addition, expression of Il1rl1 (encoding ST2) and chemokine receptors Ccr2, Ccr9, and Ccr10 was upregulated by BATF, but not JunB (Fig. 6b) . These data indicate that JunB and BATF regulate shared and unique target genes in the eTreg transcriptional program.
To elucidate mechanisms underlying JunB-dependent transcriptional regulation, we conducted chromatin immunoprecipitation-sequencing (ChIP-Seq) analysis using antibodies against JunB, as well as against BATF and IRF4. We found that JunB-binding peaks overlapped significantly with BATF-and IRF4-binding peaks (Supplementary Fig. 9a ). Among peaks identified around gene-encoding regions (within 100 kb of transcription start site), 35% of JunB peaks overlapped with BATF and IRF4 ( Supplementary Fig. 9b ). Furthermore, among peaks located around eTreg-related genes, higher numbers of JunB peaks (47%) overlapped with BATF and IRF4 (Supplementary Fig. 9c ). As in previously reported data for Th17 and CD8 + T cells [36] [37] [38] [39] [40] , de novo motif analysis identified AICE motifs in overlapping ChIP-seq peaks for JunB, BATF, and IRF4 ( Supplementary Fig. 9d ). We next investigated whether JunB is required for DNAbinding of IRF4 by ChIP-seq analysis for IRF4 in Junb-sufficient and Junb-deficient Treg cells. Global analysis of ChIP-seq peaks revealed that levels of IRF4 DNA-binding were significantly decreased in 28% of ChIP-seq peaks that overlapped for IRF4 and JunB (3190 out of 13,813 peaks, > 2× changes). De novo motif analysis identified AP-1 and AICE motifs in overlapping ChIPseq peaks for JunB and IRF4, in which levels of IRF4-binding were downregulated by JunB deficiency (supplementary Fig. 9e) , implying the importance of JunB for DNA-binding of IRF4 at a subset of loci containing AICE motifs. We noted that at IRF4-binding sites located between Icos and Ctla4, both of which are upregulated by JunB and IRF4 in Treg cells, levels of some IRF4 peaks were reduced in Junb-deficient Treg cells (Fig. 6c) . To confirm this, we performed ChIP for IRF4 followed by PCR analysis using primers to detect genomic regions in which significant decreases of DNA-binding of IRF4 by JunB deficiency were shown in ChIP-seq data. JunB deficiency considerably reduced IRF4 binding to sites located near Icos, Ctla4, Gzmb, and Maf ( Fig. 6d and Supplementary Fig. 9f, g ). In contrast, at IRF4-binding sites located near Prdm1 and Gata3, DNA binding of IRF4 and BATF was not affected by JunB deficiency (Supplementary Fig. 9h, i) . We also confirmed that JunB deficiency did not affect expression levels of IRF4 and BATF in eTreg cells ( Supplementary Fig. 1e, f) . These data suggest that JunB serves key functions in expression of a subset of IRF4-dependent, eTregrelated genes, probably by promoting DNA-binding of IRF4 at sites associated with those genes.
Discussion
The TCR-dependent eTreg transcriptional program is indispensable for Treg cells to maintain immune homeostasis 6 . Upon TCR stimulation, IRF4 is induced and transcriptionally regulates a variety of eTreg-related genes 7 . In addition, an AP-1 transcription factor, BATF, which can interact with IRF4 to bind AICE motifs, is also required for eTreg differentiation 11, 24, 49 . However, it remains largely unclear how the IRF4-dependent eTreg program is regulated by AP-1 transcription factors. In this study, we show that the AP-1 transcription factor, JunB, as well as BATF and IRF4, are highly expressed in ICOS + eTreg cells. JunB is critical for accumulation and suppressive functions of eTreg cells, and Treg-specific ablation of JunB results in multi-organ autoimmunity. Unlike IRF4, which is absolutely necessary for CD62L lo eTreg generation, JunB regulates expression of a limited set of key effector molecules, such as ICOS and CTLA4, presumably by regulating DNA-binding activity of IRF4 in a locusspecific manner.
Our ChIP-seq data indicate that JunB colocalizes with BATF and IRF4 at loci of large numbers of eTreg-related genes containing AICE motifs. However, our RNA-seq data show that JunB is needed for expression of only a small subset of eTreg-related genes, such as Icos, Klrg1, Tigit, Ctla4, and Gzmb, in Treg cells. Interestingly, although JunB and BATF regulate some shared target genes, such as Icos and Klrg1, each regulates a unique set of genes (e.g., Il1rl1 and Prdm1 for BATF, and Ctla4 and Tigit for JunB). JunB likely promotes accumulation of IRF4 at loci of selective eTreg-related genes, as loss of JunB severely decreases DNA-binding of IRF4 at its target sites located near Icos, Ctla4, Gzmb, and Maf. In addition, the necessity of JunB for IRF4-dependent gene expression is likely context-dependent. For example, expression of CTLA4 and TIGIT is decreased in eTreg cells derived from Cd4 Cre Junb fl/fl mice, but not from Foxp3 CreJunb fl/fl mice, although expression of ICOS is decreased in eTreg cells derived from both types of mice. In contrast, expression of GATA3 and T-bet is diminished in eTreg cells derived from JunB is also important for accumulation of eTreg cells in peripheral tissues, particularly in the colon. As an adhesion molecule CD44 is involved in T-cell migration to inflammatory tissues 55 induce JunB and BATF, but CD28 and IL-2 signals promote expression of JunB and BATF in an additive manner in the presence of CD3 signaling. In contrast, IRF4 expression is induced by CD3 signaling alone and is further augmented by CD28 and IL-2 signals, but there is no additive effect between CD28 and IL-2 signals. In addition, expression of BATF and IRF4 is transcriptionally upregulated, but JunB expression is regulated post-transcriptionally in activated Treg cells. The mechanism of post-transcriptional regulation of JunB expression may include JNK-phosphorylation-mediated stabilization of JunB protein 50 . Moreover, Treg cells express rather high levels of JunB, BATF, and IRF4 in lung compared with spleen, suggesting that tissuespecific signals modulate expression of JunB in peripheral tissues. These observations suggest that JunB, by cooperating with BATF and IRF4, integrates diverse signals to induce specific types of eTreg cells. Furthermore, heterogeneity in expression of these transcription factors can be generated during differentiation of eTreg cells, which might contribute to functional heterogeneity of eTreg cells.
In summary, we identify JunB as a key regulator of IRF4 activity in the eTreg transcriptional program. JunB serves nonredundant functions to facilitate expression of a subset of IRF4 target genes in BATF-dependent and -independent fashions. Thus, JunB could be a target for therapeutic manipulation of specific functions of eTreg cells in immune and autoimmune responses.
Methods
ChIP-PCR analyses. Primers used for ChIP-PCR were listed in Supplementary  Table 1 .
To prepare ChIP-seq libraries, immunoprecipitated DNA was blunt-ended and ligated with adaptors using a KAPA Hyper Prep Kit (KAPA Biosystems; KK8500). DNA was then cleaned up with an Agencort AMPure XP (Beckman Coulter; A63880) at a 1.8 × DNA ratio, amplified by PCR, and purified using the AMPure XP at a 1.2 × DNA ratio. Library DNA was size-selected using a 2% agarose gel cassette of Blue Pippin (Sage Science) for a target size range 150-300 bp, quantified with droplet digital PCR (Bio-Rad), and then sequenced on an Illumina HiSeq4000 to obtain 10 million uniquely aligned reads.
In vitro Treg suppression assay. Responder CD4 + T cells were isolated from B6. SJL (CD45.1) mice and stained with CTV (Thermo Fisher Scientific; C34751). CTV-stained responder cells (5 × 10 4 cells/well) were cultured alone or together with CD4 + CD25 + Treg cells, isolated freshly or pre-activated by anti-CD3/CD28 antibodies plus IL-2 for 2 days, in the presence of anti-CD3/CD28-coated Dynabeads (Invitrogen; 11456D; 1.25 × 10 4 beads/well). On day 3, cells were stained for CD45.1, CD45.2, and CD4 and analyzed by flow cytometry.
In vivo Treg suppression assay. Rag1 −/− mice were intraperitoneally injected with CD4 + CD62L hi CD44 lo CD25 -naive T cells (4 × 10 5 cells per mouse) isolated from spleens and lymph nodes of wild-type C57BL/6 mice, together with or without CD4 + CD25 hi Treg cells (2 × 10 5 cells per mouse) isolated from spleens and lymph nodes of Cd4 Cre Junb fl/fl or Junb fl/fl mice. Mice were weighed to monitor disease progress.
Mixed BM chimera mice. Rag1 −/− recipient mice were lethally irradiated by X-ray with a single dose of 6.5 Gy and 1 day later intravenously injected with a 1:1 mixture of BM cells from B6SJL (CD45.1) mice and Cd4 Cre Junb fl/fl or Junb fl/fl mice (1 × 10 7 cells per mouse). Mice were given drinking water containing 1 mM Trimethoprim (Sigma-Aldrich; 46984) and 5 mM Sulfamethoxazole (Sigma-Aldrich; 31737) for 1 week before and after irradiation. Mice were maintained for at least 2 months after transplantation and used for analysis.
Statistical analysis. Unpaired two-tailed Student's t tests were performed using Prism software (GraphPad). P values < 0.05 were considered statistically significant.
Data availability
The RNA-seq and ChIP-seq data have been deposited in the Gene Expression Omnibus with the primary accession code GSE121295. CyTOF data were uploaded in Cytobank (this data will be available from the authors upon request). All other data supporting the findings of this study are available from the authors on request.
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